DE2148865C3 - Verwendung eines Streptokinase-Plasminogen-Komplexes zur Fibrinolyse - Google Patents

Verwendung eines Streptokinase-Plasminogen-Komplexes zur Fibrinolyse

Info

Publication number
DE2148865C3
DE2148865C3 DE2148865A DE2148865A DE2148865C3 DE 2148865 C3 DE2148865 C3 DE 2148865C3 DE 2148865 A DE2148865 A DE 2148865A DE 2148865 A DE2148865 A DE 2148865A DE 2148865 C3 DE2148865 C3 DE 2148865C3
Authority
DE
Germany
Prior art keywords
streptokinase
plasminogen
complex
fibrinolysis
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2148865A
Other languages
German (de)
English (en)
Other versions
DE2148865B2 (de
DE2148865A1 (de
Inventor
Hansjörg Dr. Ronneberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE789596D priority Critical patent/BE789596A/xx
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DE2148865A priority patent/DE2148865C3/de
Priority to CA152,315A priority patent/CA980689A/en
Priority to NL7212945.A priority patent/NL156051B/xx
Priority to CH1420572A priority patent/CH580963A5/xx
Priority to AT840172A priority patent/AT316753B/de
Priority to FR7234644A priority patent/FR2154756B1/fr
Priority to JP9794772A priority patent/JPS557408B2/ja
Priority to DK484372A priority patent/DK133496C/da
Priority to GB4543172A priority patent/GB1384932A/en
Publication of DE2148865A1 publication Critical patent/DE2148865A1/de
Priority to US05/917,583 priority patent/US4178368A/en
Publication of DE2148865B2 publication Critical patent/DE2148865B2/de
Application granted granted Critical
Publication of DE2148865C3 publication Critical patent/DE2148865C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE2148865A 1971-09-30 1971-09-30 Verwendung eines Streptokinase-Plasminogen-Komplexes zur Fibrinolyse Expired DE2148865C3 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
BE789596D BE789596A (fr) 1971-09-30 Activateur de fibrinolyse et son procede de preparation
DE2148865A DE2148865C3 (de) 1971-09-30 1971-09-30 Verwendung eines Streptokinase-Plasminogen-Komplexes zur Fibrinolyse
CA152,315A CA980689A (en) 1971-09-30 1972-09-22 Fibrinolysis activator and process for its manufacture
NL7212945.A NL156051B (nl) 1971-09-30 1972-09-25 Werkwijze voor het bereiden van streptokinase en plasminogeen houdende preparaten.
CH1420572A CH580963A5 (enExample) 1971-09-30 1972-09-28
FR7234644A FR2154756B1 (enExample) 1971-09-30 1972-09-29
AT840172A AT316753B (de) 1971-09-30 1972-09-29 Verfahren zur Herstellung eines Fibrinolyseaktivators
JP9794772A JPS557408B2 (enExample) 1971-09-30 1972-09-29
DK484372A DK133496C (da) 1971-09-30 1972-09-29 Fremgangsmade til fremstilling af en streptokinaseholdig fibrinolyseaktivator
GB4543172A GB1384932A (en) 1971-09-30 1972-10-02 Fibrinolysis activator and process for its manufacture
US05/917,583 US4178368A (en) 1971-09-30 1978-06-21 Method for the treatment of thromboembolism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2148865A DE2148865C3 (de) 1971-09-30 1971-09-30 Verwendung eines Streptokinase-Plasminogen-Komplexes zur Fibrinolyse

Publications (3)

Publication Number Publication Date
DE2148865A1 DE2148865A1 (de) 1973-04-05
DE2148865B2 DE2148865B2 (de) 1980-07-24
DE2148865C3 true DE2148865C3 (de) 1981-04-23

Family

ID=5821086

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2148865A Expired DE2148865C3 (de) 1971-09-30 1971-09-30 Verwendung eines Streptokinase-Plasminogen-Komplexes zur Fibrinolyse

Country Status (10)

Country Link
JP (1) JPS557408B2 (enExample)
AT (1) AT316753B (enExample)
BE (1) BE789596A (enExample)
CA (1) CA980689A (enExample)
CH (1) CH580963A5 (enExample)
DE (1) DE2148865C3 (enExample)
DK (1) DK133496C (enExample)
FR (1) FR2154756B1 (enExample)
GB (1) GB1384932A (enExample)
NL (1) NL156051B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659452A (en) * 1979-10-20 1981-05-22 Hitachi Maxell Ltd Manufacture of dry cell
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel
JPWO2008047669A1 (ja) 2006-10-16 2010-02-25 日本板硝子株式会社 モール付きガラス

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3019167A (en) * 1959-05-01 1962-01-30 Innerfield Irving Method of administering streptokinase systemically
US3274059A (en) * 1961-11-13 1966-09-20 Merck & Co Inc Stable-enhanced plasmin solutions

Also Published As

Publication number Publication date
AT316753B (de) 1974-07-25
NL7212945A (enExample) 1973-04-03
JPS4840921A (enExample) 1973-06-15
CH580963A5 (enExample) 1976-10-29
DE2148865B2 (de) 1980-07-24
DK133496C (da) 1976-10-18
BE789596A (fr) 1973-04-02
DE2148865A1 (de) 1973-04-05
NL156051B (nl) 1978-03-15
FR2154756B1 (enExample) 1976-04-23
GB1384932A (en) 1975-02-26
CA980689A (en) 1975-12-30
JPS557408B2 (enExample) 1980-02-25
DK133496B (da) 1976-05-31
FR2154756A1 (enExample) 1973-05-11

Similar Documents

Publication Publication Date Title
DE2036114C3 (de) Wäßriges Tetramisolpräparat
DE3150318C2 (de) "Verfahren zur Herstellung eines Polysaccharidderivats des Fibrinolysins"
DE1927209A1 (de) Acyl-substituierte Insuline und Verfahren zu ihrer Herstellung
CH639854A5 (de) Gefriergetrocknetes natives gammaglobulin-praeparat zur intravenoesen verabreichung und verfahren zu seiner herstellug.
DE2331550A1 (de) Festes proteinprodukt enthaltend fibrinogen
WO1988002261A1 (fr) Utilisation de hyaluronidase
CH657376A5 (en) Process for the preparation of gamma-globulin for intravenous injection
DE2148865C3 (de) Verwendung eines Streptokinase-Plasminogen-Komplexes zur Fibrinolyse
DE2639012C3 (de) Inununtherapeutikum zur Prophylaxe und Therapie von Pseudomonas aeruginosa-Infektionen
DE2710728C2 (de) Reagens für die radiologische Abtastung von Organen, Verfahren zu seiner Herstellung und seine Verwendung
DE1617805A1 (de) Verfahren zur Herstellung von Lysozym
DE2515666C3 (de) Piasminreiche Gammaglobulinfraktion, Verfahren zu deren Herstellung und das Verfahrensprodukt enthaltendes Gammaglobulinpräparat
DE960579C (de) Verfahren zur Herstellung eines in der Hitze sterilisierbaren Adrenocorticotropin-Praeparates
DE2036113C3 (de) Wäßriges Tetramisolpräparat
DE68913212T2 (de) Ein reines faktor i-protein und verfahren zur herstellung.
US2145869A (en) Intravenous therapy for the treatment of syphilis
DE375108C (de) Verfahren zur Herstellung eines Impfstoffes aus lebenden nativen oder mit Immunserum vorbehandelten saeurefesten Bazillen
DE2441621A1 (de) Arzneimittel zur behandlung von augenerkrankungen
DE3023396C2 (de) Arzneimittel zur intravenösen Krebstherapie
US4853373A (en) Therapeutic treatment for arthritic condition
DE2925345C2 (de) N[β-(2-Mercaptoäthylcarbamoyl)-äthyl]-phenoxyalkansäureamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE1942900B2 (de) Verfahren zur abtrennung von l-asparaginase aus bakterienkulturen, danach hergestellte l-asparaginase und diese enthaltendes therapeutisches mittel
DE68905392T2 (de) Penizillinpraeparat zur rektalen verabreichung.
HALLMAN et al. On the use of hyaluronidase on hypodermoclysis in infants
DE2043330C3 (de) Polymere Stoffe aus l-Methyl-5-(5-OXO-4 äthyl-tetrahydrofuryl-(3)methyO-imidazol und Celluloseglykolsäure, Verfahren zu deren Herstellung und diese Stoffe enthaltende Arzneimittel

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee